Innovation-driven domain for biotech startups
signals.bio (signals.bio) earns a Brand Analyzer score of 72 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, Other brands. Among 4769 Healthcare brands analyzed, signals.bio ranks in the 41st percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 81/100, Visual Identity 98/100, Messaging Clarity 95/100, Trust Foundation 59/100, AI Discoverability 61/100, Brand Authority 48/100.
signals.bio is a domain name currently listed for sale as a verified, premium domain. It is marketed toward entrepreneurs and startups in the biotech, genetics, and healthcare sectors as a short, brandable name intended to convey innovation and technological credibility. The site itself does not operate as a business beyond facilitating the domain sale, offering purchase or installment payment options with free transaction support and no extra fees. Separately, 'Signals' is also the name of a 2013 album by the band Mallory Knox, unrelated to the domain listing.
| Brand Name | signals.bio |
|---|---|
| Domain | signals.bio |
| Industry | Healthcare, Technology |
| Main Competitors | GoDaddy (88/100), Sedo (92/100), Squadhelp (89/100), BrandBucket (74/100), Afternic (92/100), Dan.com (89/100), Namecheap Marketplace (95/100) |
Moz Domain Authority 3/100 vs category average 38 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
signals.bio has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "signals.bio is a verified domain available for purchase. Buy now or pay in installments. Free transaction support, no extra fees." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), Instagram, LinkedIn, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
signals.bio scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
signals.bio has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (55/100) and its weakest is trust (7/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 3/100, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check (August 2026), Claude could not identify signals.bio from memory, confirming the gaps above.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is signals.bio?", Claude could not identify the brand as of August 2026. I don't have specific knowledge of signals.bio, likely because it's a small or newer company in the healthcare/biotech space without significant presence in my training data.
When asked "Best brands similar to signals.bio?", Claude would not surface signals.bio as of August 2026. I can't recommend a company I don't have verified information about.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
signals.bio's main competitors include GoDaddy (88/100), Sedo (92/100), Squadhelp (89/100), BrandBucket (74/100), Afternic (92/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
signals.bio and Namecheap Marketplace are competitors in Healthcare. Brand Analyzer scores signals.bio at 72/100 and Namecheap Marketplace at 95/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to signals.bio include GoDaddy (88/100), Sedo (92/100), Squadhelp (89/100), BrandBucket (74/100), Afternic (92/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
signals.bio has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 55, trust 7, recommendation 41). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: signals.bio official site
signals.bio scores 41/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: signals.bio official site
The primary offering associated with signals.bio is the domain name itself, sold either as a one-time purchase or through installment payments. The seller also provides free transaction support intended to facilitate the domain transfer process without additional fees. No other products or services are indicated in the available facts.
Sources: signals.bio official site
signals.bio is a domain name listed for sale on a domain marketplace. It is described as a verified, premium, brandable domain intended for use by companies in the biotech, genetics, or healthcare fields. The seller offers the domain for purchase outright or via installment payments, along with free transaction support and no extra fees.
Sources: signals.bio official site
signals.bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: signals.bio official site
signals.bio functions as a for-sale domain listing rather than an active business or service. Its role is to be acquired by a startup or company-particularly one in biotech, genetics, or healthcare-as its official web address and brand name. The listing itself facilitates the transaction, including installment payment options and transaction support, but does not provide any biotech or healthcare service.
Sources: signals.bio official site
signals.bio is known for being a short, memorable, 7-letter, 2-syllable premium domain name marketed toward biotech, genetics, and healthcare startups. It is positioned as a distinctive, brandable web address rather than as an operating company or product.
Sources: signals.bio official site
The intended users of signals.bio are entrepreneurs and startups operating in the biotech, genetics, and healthcare industries who are seeking a short, brandable domain name to help establish a distinctive market identity.
Sources: signals.bio official site
Ranked closest to signals.bio: MilliporeSigma (72/100), Shepherd Veterinary Clinic (72/100), SirenGPS (72/100), Sky Solutions (72/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).